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Desmoid tumours are locally invasive soft tissue tumours in which b-catenin mediated TCF-dependent transcription is activated. The
role of soluble factors secreted by the myofibroblastic desmoid tumour, which could stimulate tumour invasiveness, was investigated.
Using collagen gel invasion assays, the presence of factors stimulating invasion in desmoid conditioned media (CM) could be
established. Since matrix metalloproteinases (MMPs) have been implicated in the process of tumoral invasion, the expression levels of
the MMP family members were evaluated. Quantitative reverse transcription–PCR was used to determine the expression levels of
MMP1, MMP2, MMP3, MMP7, MMP11, MMP12, MMP13, MMP14 and the inhibitors TIMP1, TIMP2 and TIMP3. Besides
overexpression of MMP7, a known TCF-dependent target gene, a striking upregulation of the expression levels of MMP1, MMP3,
MMP11, MMP12 and MMP13 in desmoid tumours, compared to unaffected fibroblasts from the same patients, was found. Treating
the CM of desmoids with a synthetic and a physiologic MMP inhibitor reduced the invasion-stimulating capacity of the desmoid CM
by approximately 50%. These results suggest the involvement of soluble factors, released by the desmoid cells, in stimulating invasion
and implicate the MMPs as facilitators of invasion.
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Desmoid tumours (also called aggressive fibromatosis) are locally
invasive, benign soft tissue tumours, composed of a clonal
proliferation of fibroblast-like cells with characteristics of myofibro-
blasts. They can occur as sporadic lesions or as part of familial
adenomatous polyposis, which is caused by germline mutations in
the adenomatous polyposis coli (APC) gene. Sporadic desmoids
h a r b o u rs o m a t i cm u t a t i o n si ne i t h e rt h eA P Cg e n eo ri nt h eb-catenin
gene, resulting in b-catenin protein stabilisation (Li et al, 1988; Tejpar
et al, 1999). Previously, we demonstrated constitutive TCF activation
in primary desmoid cell cultures and showed that b-catenin binds
and activates TCF-3 in these tumours (Tejpar et al, 2001).
Although desmoids are classified as benign tumours, they can be
very invasive and aggressive. They invade surrounding viscera and
neurovascular structures, which may cause significant morbidity
and mortality (Lewis et al, 1999). The aggressive growth pattern
and their tendency for recurrence make these tumours difficult to
treat. As desmoids are locally invasive lesions, cells from the
tumour may need to produce factors in order to promote invasion
into the extracellular matrix (ECM).
Tumour invasion is a complex process that requires interaction
between the invasive cells and the ECM. A crucial step in invasive
processes is the proteolytic degradation of the ECM and basal
membranes (Curran and Murray, 1999). Among the enzymes
responsible for ECM degradation, several studies have shown a
critical role played by matrix metalloproteinases (MMPs) (De
Clerck et al, 1992). Matrix metalloproteinases are zinc-dependent
endopeptidases, which are collectively capable of degrading all
constituents of the ECM. Based on their structure and substrate
specificity, they can be divided into subgroups of collagenases,
stromelysins, gelatinases, membrane-type MMPs and other MMPs.
In this study, we will show the presence of invasion-stimulating
factors in desmoid conditioned medium (CM) and we will examine
the MMP expression in desmoids and fascia samples. Besides
overexpression of MMP7, a known b-catenin-dependent target
gene in colon cancer, the results show an overexpression of MMP1,
MMP3, MMP11, MMP12 and MMP13 in desmoid tumours
compared to normal fibroblasts (fascia tissue). Using MMP
inhibitors in invasion assays, we will show that MMPs produced
by the desmoid tumours facilitate invasion.
MATERIALS AND METHODS
Reagents
The noncytotoxic broad-spectrum MMP inhibitor, Galardin, also
called GM6001 or Ilomastat, was dissolved in DMSO and was
kindly provided by Dr Kjeld Dan (The Finsen Laboratory,
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sCopenhagen, Denmark or purchased from Raylo Chemicals,
Edmonton, Canada). An inactive structural analogue of Galardin
was dissolved in matched volumes of DMSO and served as negative
control (Calbiochem, La Jolla, CA, USA). The serine proteinase
inhibitor Aprotinin was purchased from ICN Pharmaceuticals
(Costa Mesa, CA, USA), recombinant TIMP1 was from R&D
Systems (Abingdon, UK). Mouse anti-human MMP7 monoclonal
antibody was bought from Chemicon (Hofheim, Germany).
Soluble type I collagen, derived from rat-tail, was purchased from
Upstate Biotechnology (Lake Placid, NY, USA).
Cell cultures
Primary cell cultures of seven desmoid tumours and their normal
fascia controls (patients consented for the use of their tissue) were
derived by collagenase treatment of tissue biopsies and grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies,
Ghent, Belgium) supplemented with 10% fetal calf serum (FCS). All
studies were performed using cultures in passage two.
To prepare serum-free CM, cells were harvested by trypsinisa-
tion, counted and 1 10
6 cells were cultured in DMEM with 10%
FCS in T-75 culture flasks (BD Falcon, Sint-Niklaas, Belgium).
After 24h, cells were washed three times with phosphate-buffered
saline, incubated with serum-free medium for 12h, followed by
change of medium and incubation in 6ml serum-free medium.
This 6ml of CM was collected 48h later, centrifuged and stored at
 701C until use, a procedure that did not alter its biological
activity as tested with 6 months old CM. Conditoned medium of
fibroblasts or desmoid was 5  concentrated in centriprep tubes
YM-10 (Amicon, Millipore Corp., Bedford, MA, USA) and passed
through a filter with a 0.22mm pore size, before testing its
invasion-stimulating capacity.
HCT-8/E11 (E, epithelioid morphotype) is a cloned human
colon cancer cell line cultured as described earlier (Vermeulen
et al, 1995).
The LoVo cell line was purchased from the American Type
Culture Collection (ATCC, Rockville, MD, USA; CCL 229). The
CCL 229 cell line is derived from a metastatic nodule in the left
supraclavicular region of a 56-year-old patient with histologically
proven diagnosis of adenocarcinoma of the colon (Drewinko et al,
1976).
Sulphorhodamine B assay
Sulphorhodamine B assay according to Skehan’s method was used
to examine cell toxicity (Skehan et al, 1990). Experiments were run
in octoplet, and were repeated twice.
Invasion assays
Invasion assays were performed according to Bracke et al (2001).
Briefly, six-well plates were filled with 1.25ml of neutralised type I
collagen solution and polymerised at 371C. A measure of 500mlo f
5  concentrated CM of fascia or desmoid cultures of equal cell
numbers together with 500ml of medium containing 1 10
5 HCT-
8/E11 cells were seeded on top of the collagen and incubated at
371C during 24h. Invasion was measured using an inverted
microscope controlled by a computer program. Invasive and
superficial cells were counted in 10 fields of 0.157mm
2. The
invasion index was expressed as the percentage of cells invading
the gel over the total number of cells added. None of the agents
tested in the 24h invasion assay interfered with viability (Trypan
blue exclusion test). Invasion chambers were prepared by coating
10mm tissue culture inserts with 8mm polycarbonate membrane-
modified Boyden chamber inserts (Becton-Dickinson) with 85mg/
cm
2 Matrigel (Becton-Dickinson). In a similar manner, 1 10
5cells
derived from desmoid tumours were cultured onto the top
chamber of invasion chamber with and without the addition of
Ilomastat. The cells were allowed to migrate across the membrane
for 24h. The Matrigel and cells were removed from the top half of
the membrane, and number of cells crossing the membrane was
averaged over 10 high-powered fields (hpf’s) counted, after
staining the cell nuclei with 4,6-diamidino-2-phenylindole (DAPI).
Quantitative reverse transcription (RT)–PCR
Total RNA was extracted from primary desmoid and fascia
cultures using the RNeasy kit (Qiagen). Reverse transcription –
PCR for all MMPs (except for MMP7) and TIMPs was carried out
as follows. The mRNA of interest and the 28S rRNA were
quantified by RT–PCR using 10ng of total RNA. For each mRNA,
the sequences of primers, the optimal conditions of reaction
(number of amplification cycles and temperatures) and the
amount of primers and internal standards were used as previously
described (Nusgens et al, 2001; Lambert et al, 2001), in order to be
within the linear range of measurement under noncompetitive
conditions. The efficiency of the RT and the amplification
reactions was monitored by adding in each tube an appropriate
number of copies of a synthetic RNA (sRNA) that can be reverse-
transcribed and amplified with the primer pair used for the
endogenous mRNA of interest, but giving rise to a product slightly
larger or smaller than the product amplified from mRNA, allowing
its discrimination after migration in a 10% polyacrylamide gel.
After migration, the gels were stained with Sybergreen (Biorad,
Hercule, CA, USA) or Gelstar (FMC Bioproducts, Rockland, ME,
USA) and the intensity of the fluorescent signals was measured in a
fluor-S-MultiImager (Biorad). Each measurement was normalised
to the cotranscribed and coamplified internal standard. The
normalised values were expressed in arbitrary units (AU) per unit
of 28S rRNA measured in the same dilution of RNA to correct for
RNA input of each sample. For negative controls, RT–PCR was
performed without cellular RNA.
Quantitative RT–PCR for MMP7 was carried out by ABI Prism
7700 (Applied Biosystems). Probes and primers for MMP7 and
porphobilinogen deaminase (PBGD), the internal control, were
designed by Primer Express 1.0 (Applied Biosystems). The probes
were labelled on the 50 end by FAM and 30 end by TAMRA. The
primer sequences for MMP7 and PBGD are available on request.
TaqMan master mix kit from Eurogentec was used and the general
PCR conditions were applied as recommended by Applied
Biosystems. Standard curves for MMP7 and PBGD were drawn
by Excel (Microsoft) upon the threshold cycle (Ct) values and the
relative concentrations of the standards and the relative concen-
trations for desmoid and fascia samples were calculated from the
detected Ct values and the equation of the curves. The values
obtained for MMP7 were divided by the values of PBGD to
normalise for differences in RT.
Casein zymography
Conditioned medium obtained from equal cell numbers was
concentrated 25  and 20ml was treated with nonreducing sample
buffer without boiling. Tris-Glycine polyacrylamide precast gel
electrophoresis was performed using a 12% polyacrylamide gel
containing 0.05% casein (Invitrogen, Merelbeke, Belgium). After
electrophoresis, gels were washed for 2 30min in 2% Triton X-
100 solution at room temperature and incubated overnight at 371C
in MMP substrate buffer (50mM Tris-HCl, pH 7.5, 10mM CaCl2).
Gels were rinsed again in distilled water, stained with 0.5%
Coomassie brilliant blue R-250 in 40% methanol and 10% acetic
acid for 20min, and destained with 40% methanol and 10% acetic
acid. Proteolytic activities appeared as clear bands of lysis against a
dark background of stained casein. To verify that the detected
caseinolytic activities were specifically derived from MMPs, the
gels were incubated in the MMP substrate buffer with 10mM
EDTA. To verify that Galardin inhibited caseinolytic activity, the
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sgels were incubated in the MMP substrate buffer with 10mM
Galardin or 10mM of its structural analogue (negative control).
We verified that Galardin does not inhibit caseinolytic activity
caused by serine proteinases. Therefore, the serine proteinase
plasmin was used and the gels were incubated in the serine
proteinase substrate buffer (50mM Tris-HCl, pH 7.5, 100mM
glycine and 15mM EDTA) with or without 10mM Galardin.
Immunohistochemistry
Deparaffinised sections were incubated for 30min with 0.3%
hydrogen peroxide in methanol and microwave heated in EDTA
buffer. Subsequently, an indirect immunoperoxidase technique
was applied, using mouse anti-human monoclonal MMP7 antibody
(dilution 1/300). Negative controls consisted of omission of the
primary antibody.
RESULTS
Desmoid CM is able to stimulate invasion
Desmoids are locally very invasive tumours. To study their
invasive character, collagen invasion assays were performed,
which showed that desmoid cells were invasive in type I collagen
gels (8.0%, s.d. 2.0) and that their invasion capacity could be
stimulated by addition of desmoid CM (10.8%, s.d. 1.2) (Figure 1A).
To test the hypothesis that invasion-stimulating soluble factors
were present in desmoid CM, collagen invasion assays with HCT-8/
E11 colon cancer cells were performed. These colon cancer cells
were used as a model because it was previously shown that they
were noninvasive in type I collagen, but can become invasive
depending on stimulation (Debruyne et al, 2002; Regnauld et al,
2002; Nguyen et al, 2002). In the presence of normal medium
(DMEM), no invasion of the cells into the collagen was observed.
By replacing DMEM with the 5  concentrated desmoid CM, an
invasion of 6.9% of the HCT-8/E11 cells into the collagen gel
(Figure 1B) was observed after 24h. The experiments were also
performed using CM of primary fascia cultures from the same
patients. The 5  concentrated fascia CM had no or minimal
invasion stimulatory effects on the HCT-8/E11 cells. Similar results
were obtained using the colorectal cancer cell line LoVo. In the
presence of normal medium, 2.2% (s.d. 1.1) of the LoVo cells
invaded into the collagen. Addition of desmoid CM resulted in an
invasion of 9.7% (s.d. 0.8) of the LoVo cells into the collagen gel.
These results suggest the presence of invasion-stimulating
soluble factors in the desmoid CM.
Overexpression of MMPs in desmoid tumours
Affymetrix microarray and Atlas Blots (Clontech) were utilised to
screen for genes overexpressed in desmoid tumours compared to
normal fascia from the same patients (data not shown). These
preliminary data suggested that MMPs were overexpressed and
tissue inhibitors of MMPs (TIMPs) underexpressed in desmoid
tumour cells.
mRNA expression profiles of MMP1, MMP2, MMP3, MMP11,
MMP12, MMP13 and MMP14 in four desmoid vs fascia samples
were performed by quantitative RT–PCR using specific sRNA as
internal standards. The results are expressed as arbitrary units
corrected by the internal standard, per unit of 28S. A striking
overexpression of MMP1, MMP3, MMP11, MMP12 and MMP13 in
the desmoid samples was found, as shown in Table 1 and Figure 2.
There was no significant difference in the mRNA expression levels
of MMP2 and MMP14 between the desmoid and fascia samples in
these four cases and according to the microarray results, MMP9
was not expressed above background level in most desmoids (data
not shown). For the expression profile of MMP7 in desmoids,
TaqMan RT–PCR was used. Results were expressed as the relative
expression in desmoids against the corresponding fascia and were
normalised for the housekeeping gene PBGD (Table 2). Matrix
metalloprotein 7 was upregulated (mean average 33.9-fold) in all
desmoids tested compared to the corresponding fascia. Immuno-
histochemistry confirmed MMP7 expression at the protein level in
desmoid tumour cells and tumour-associated endothelial cells in
vivo (Figure 3). Adipocytes and occasional lymphocytes did not
reveal any staining.
Zymography was used to confirm the overexpression of
caseinolytic MMPs or stromelysins at the protein level. The CM
of desmoids clearly showed higher caseinolytic activity than the
fascia CM (Figure 4). To verify that the detected caseinolytic
activities were specifically derived from MMPs, the gels were
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Figure 1 Collagen gel invasion assays with desmoid and HCT-8/E11
cells. (A) Desmoid cells were seeded on top of collagen type I gel and
incubated with (I) normal medium or (II) CM of desmoid cultures. (B) The
HCT-8/E11 cells were seeded on top of collagen type I gel and incubated
with (I) normal medium; (II) CM of desmoid cultures; (III) CM of fascia
cultures. The invasion indexes were calculated as the number of cells inside
the gel over the total number of cells. Values are means7s.d. of four
different experiments, performed in duplicate.
Table 1 mRNA levels of MMP1, MMP3, MMP11, MMP12, MMP13,
TIMP1 and TIMP3
Target Tissue Mean value (range)
MMP1 Desmoid 0.723 (0.187–1.958)
Fascia 0.131 (0.043–0.237)
MMP3 Desmoid 3.980 (1.232–8.301)
Fascia 0.161 (0.005–0.372)
MMP11 Desmoid 0.847 (0.431–1.450)
Fascia 0.083 (0.024–0.139)
MMP12 Desmoid 0.363 (0.029–1.196)
Fascia 0.003 (0.002–0.003)
MMP13 Desmoid 0.285 (0.132–0.633)
Fascia 0.022 (0.011–0.034)
TIMP1 Desmoid 0.600 (0.290–1.038)
Fascia 1.323 (0.858–2.047)
TIMP3 Desmoid 0.642 (0.516–0.897)
Fascia 1.406 (0.824–1.819)
Values are expressed in arbitrary units per unit of 28S rRNA. Mean value is the
average of measurements in four different desmoids and fascia samples.
Invasion and MMP expression
H Denys et al
1445
British Journal of Cancer (2004) 90(7), 1443–1449 & 2004 Cancer Research UK
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
sincubated with the MMP substrate buffer with 10mM EDTA. No
caseinolytic activity was observed after treatment with EDTA. To
verify that Galardin inhibited caseinolytic activity, the gels were
incubated in the MMP substrate buffer with 10mM Galardin.
Treatment with Galardin inhibited the caseinolytic activity
(Figure 4). Same concentrations of Galardin did not inhibit
caseinolytic activity by the serine proteinase plasmin, indicating
the specificity of Galardin as an MMP inhibitor (data not shown).
These results suggested that the caseinolytic bands in the desmoid
CM are due to MMPs that are sensitive to Galardin. In conclusion,
the MMP expression profile in desmoid tumours showed an
upregulation of especially stromelysins and collagenases, but no
significant expression or differential expression of gelatinases.
Since physiologic inhibitors regulate the proteolytic activities of
MMPs, the expression levels of TIMPs, TIMP1, TIMP2 and TIMP3
were examined by quantitative RT–PCR using specific sRNA as
internal standards. In 75% of the desmoid samples, TIMP1 and
TIMP3 levels were significantly downregulated compared to the
control samples (Table 1; Figure 2). For TIMP2, the interindividual
mRNA expression was variable and no significant difference in
expression levels was observed (data not shown).
Role of MMPs in facilitating invasion
To assess the role of MMPs in facilitating invasion, invasion assays
were carried out in the presence of MMP inhibitors. Toxicity of all
inhibitors used was tested on proliferation of HCT-8/E11 cells and
28S
T1 T1 T2 T2 T3 T3 F1 F1 F2 F2 F3 F3
T1 F1 T2 T3 T4 F2 F3 F4 NC
MMP1
T1 F1 T2 T3 T4 F2 F3 F4 NC
MMP11
T1 F1 T2 T3 T4 F2 F3 F4 NC
TIMP1
A B
D C
Figure 2 Electrophoretic pattern of RT–PCR amplification products from cellular mRNA and synthetic RNA. Total RNA (10ng) from four primary
desmoid tumour (T) and fascia (F) cultures, or 2 10
5 copies of standard synthetic RNA were submitted to RT–PCR. Arrows indicate the signal obtained
for the standard RNA. (A) Expression of 28S; (B) expression of MMP1; (C) expression of MMP11; (D) expression of TIMP1. The RT–PCR products had
the expected sizes.
Figure 3 Immunoperoxidase staining of MMP7. The spindle-shaped cells
of the desmoid tumour are decorated. The vessel walls are stained as well.
Scale bar¼100mm.
Figure 4 Collected conditioned medium (CM) of desmoids and fascia
were analysed by casein zymography without or in the presence of 10mM
Galardin or 10mM of its negative control. Equal amounts of CM obtained
from equal cell numbers were subjected to electrophoresis and the gel was
processed as described in Materials and Methods. Molecular size standards
are indicated at the left. Stars (*) represents active stromelysins,
arrowheads (o) represents the prostromelysins. A representative result
of three different experiments is shown.
Table 2 RT–PCR (Taqman) expression profile of MMP7
Patient 1 Patient 2 Patient 3 Patient 4 Mean
MMP7 10.6:1 2.6:1 62.3:1 61.3:1 33.9:1
Indicative values for the relative expression ratio in desmoids against the
corresponding fascia, normalised for the housekeeping gene PBGD. Interindividual
variability while high shows the same trend in all four patients.
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sdesmoid tumour cells. None of the inhibitors influenced growth
significantly after 24h of incubation as measured with the
sulphorhodamine B assay (data not shown). The invasion capacity
of desmoid cells into the collagen gel could be partly inhibited by
Galardin (5.7%, s.d. 1.5), a synthetic MMP inhibitor, or by CM
obtained from fascia cultures (4.0%, s.d. 0.3) (Figure 5A), which
express higher levels of physiologic MMP inhibitors or TIMPs (see
Figure 2). Galardin also dose dependently decreased desmoid CM-
stimulated invasion of HCT-8/E11 cells in a type I collagen gel
(Figure 5B). At the highest concentration (10mM), Galardin
decreased the invasion of the HCT-8/E11 colon cancer cells by
approximately 50%. An inactive structural analogue of Galardin
had no significant effect on HCT-8/E11 invasion stimulated by
desmoid CM. Addition of Galardin to fascia CM had no marked
effect. Aprotinin, a broad-spectrum serine proteinase inhibitor,
had only minimal effects on desmoid-stimulated invasion of HCT-
8/E11 cells (Figure 5C). There was no additional or synergistic
effect of a combination of Galardin and aprotinin on invasion.
Similar results were obtained using desmoid cells. To examine the
putative inhibitory role of TIMPs on invasion, collagen invasion
assays were carried out with the addition of TIMP1. Similarly as
Galardin, TIMP1 dose dependently decreased desmoid CM-
stimulated invasion of HCT-8/E11 cells in a type I collagen gel
(Figure 5D).
Equal numbers of cells from primary cell cultures derived from
eight cases of desmoids and normal fibroblasts (fascia) from the
same patients were grown on Matrigel in a modified Boyden
chamber. The number of cells invading through the Matrigel was
determined by counting the number of cells reaching the lower
portion of the permeable membrane. Twice the number of
desmoid cells passed through the membrane compared to the
number of normal fibroblasts. For the desmoid cases, a mean of
19.5 (s.d. 3.4) cells per hpf passed the membrane. When treated
with an MMP inhibitor Ilomastat (¼Galardin) the number of
desmoid cells passing through the Matrigel decreased to 8.4 (s.d.
2.9) cells per hpf (Figure 6A and B), which was a significant
difference (Po0.05).
DISCUSSION
We found that cells from desmoid tumours express multiple MMPs
at higher levels than normal fibroblasts, and that cells from the
tumours express TIMPs at lower levels than do cells from normal
fibroblasts. Furthermore, desmoid cells produce soluble factors
that can stimulate cell invasion, which can be blocked partially by
inhibiting MMPs. Together, these data suggest a critical role for
MMPs in this locally invasive tumour.
Using quantitative RT–PCR, overexpression of MMP1, MMP3,
MMP7, MMP11, MMP12 and MMP13 in desmoid tumours was
demonstrated. The overexpression of stromelysins in desmoid
tumours at the mRNA level was confirmed at the protein level with
zymography. Although zymography results may not always
accurately reflect the proteolytic activity of the enzymes in vivo,
clearly higher caseinolytic activity in desmoid CM was observed.
Matrix metalloprotein 7 is commonly expressed by epithelial-
derived tumour cells, but immunohistochemical staining con-
firmed the RT–PCR data and showed that mesenchymal desmoid
cells can also express this MMP. Also, vascular endothelial cells in
desmoids expressed MMP7, which is similar as in MMP7-positive
epithelial tumours (Nagashima et al, 1997).
TIMPs can form 1:1 stoichiometric complexes with active
MMPs, resulting in the inhibition of the enzymatic activity of
almost all members of the MMP family (Gomez et al, 1997).
Therefore, the expression levels of TIMP1, TIMP2 and TIMP3 were
examined. In all the tumours analysed, there was a clear
underexpression of at least one of the TIMPs; in some tumours
there was even a downregulation of all TIMPs examined. An
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Figure 5 Invasion assays with desmoid and HCT-8/E11 cells, incubated
with MMP inhibitors, proteinase inhibitors and/or desmoid or fascia CM.
(A) Desmoid cells were seeded on top of collagen type I gel and incubated
with (I) normal medium, (II) normal medium with addition of Galardin
10mM, (III) CM of primary fascia cultures. (B) HCT-8/E11 cells were seeded
on top of collagen type I gel and incubated with: (I) desmoid CM with
addition of (Ia) control 10mM (a structural analogue of Galardin), (Ib)
Galardin 0.1mM, (Ic) Galardin 1mM and (Id) Galardin 10mM; (II) CM of fascia
cultures with addition of (IIa) control 10mM (a structural analogue of
Galardin and (IIb) Galardin 10mM.( C) HCT-8/E11 cells were seeded on
top of collagen type I gel and incubated with: (I) desmoid CM without (Ia)
or with addition of aprotinin 10mg/ml (Ib); (II) fascia CM without (IIa) or
with addition of aprotinin 10mg/ml (IIb). (D) Collagen invasion assay with
HCT-8/E11 cells incubated with desmoid or fascia CM and addition of
different concentrations of a physiologic MMP inhibitor TIMP1. (I) desmoid
CM without addition of TIMP1 (Ia), with addition of TIMP1 20ng/ml (Ib),
TIMP1 200ng/ml (Ic), TIMP1 500ng/ml (Id). (II) Conditioned medium of
fascia cultures without (IIa) and with addition of TIMP1 500ng/ml (IIb). The
invasion indexes were calculated at the number of cells inside the gel over
the total number of cells. Values are means7s.d. of four different
experiments.
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simbalance between activators and inhibitors of the MMPs,
resulting in excessive degradation of the ECM has been implicated
in tumour invasion (Tanaka et al, 1995). The demonstrated lower
expression levels of TIMPs in desmoids probably enhance the
proteolytic activities of the MMPs. However, the relationship
between MMPs and TIMPs in tumour development may be more
complex than just an imbalance between MMP and TIMP
expression, as TIMPs exhibit additional functions, some of which
may directly enhance tumour cell growth.
The increased expression of MMPs in the invasive desmoid
tumours and the ability of MMPs to degrade ECM barriers
suggested a role for these enzymes in desmoid invasion. In two
different experiments, the involvement of MMPs in desmoid
invasion could be shown. In the collagen invasion assays with
HCT-8/E11 colon cancer cells, desmoid CM treated with a broad-
spectrum MMP inhibitor resulted in a 50% decrease of the
invasion-stimulating effects of desmoid CM. Similar results were
obtained in collagen invasion assays with desmoid cells. The fact
that fascia CM also had an inhibitory effect on desmoid invasion is
probably due to the higher expression of TIMPs by the fascia cells,
as was shown by the invasion experiment with addition of TIMP1.
The Matrigel experiments also showed that the number of
desmoid cells that invaded the membrane was decreased
significantly when treated with an MMP blocking agent.
Together, these findings suggest that the invasion-stimulating
effect of desmoids are partly related to the overexpression of
MMPs.
What is activating MMP expression in desmoid tumours?
Matrix metalloprotein regulation is complex and occurs at the
levels of both gene transcription and protein activation. The
MMP genes are transcriptionally responsive to a wide variety of
external stimuli, including cytokines, growth factors and
changes in cell–cell and cell–matrix interactions. Tumour
associated expression of many MMP family members requires
the activity of a variety of oncogenic transcription factors, such as
AP-1 and Ets (Crawford and Matrisian, 1996). Matrix metallo-
protein 7 or matrilysin has been identified as a target gene of b-
catenin/TCF in colon cancer (Crawford et al, 1999). They showed
that expression of the PEA3 Ets family, in conjunction with
accumulation of b-catenin, leads to upregulation of MMP7 gene
transcription in colon cancer. In our previous work, we
demonstrated b-catenin/TCF3-mediated transcriptional activation
in desmoid tumours. Therefore, the fact that an upregulation of
MMP7 was found in desmoids suggests that it is not only a target
of b-catenin in epithelial tumours but probably also in
mesenchymal tumours. Most of the promoters of the other
overexpressed MMPs contain potential TCF binding sites, aside
from the AP-1 and ETS binding sites. So it is possible that they
may be regulated by b-catenin-mediated TCF-dependent tran-
scription, perhaps in combination with other oncogenic tran-
scription factors. During the preparation of this manuscript, two
other MMPs, MMP26 and MT1-MMP, were identified in colon
cancer as b-catenin targets (Takahashi et al, 2002; Marchenko
et al, 2002). The results of MMP overexpression in desmoids,
together with the identification of several MMPs as b-catenin
targets in colon cancer, strongly suggest an important interplay
between b-catenin signalling, matrix production and matrix
remodelling; it also suggests that one of the ways accumulated
b-catenin contributes to carcinogenesis is by activating transcrip-
tion of MMP genes.
In the entire process of cancer invasion, the local host tissue
microenvironment can be an active participant. Besides the
vascular, immune and inflammatory cells, the microenvironment
of a tumour consists mainly of myofibroblasts. An important role
for myofibroblasts was suggested by the fact that large numbers of
myofibroblasts were found near the invasive front of colon cancer
or other invasive carcinomas (Nakayama et al, 1998). Recently, it
became evident that MMPs are mostly produced by stromal cells
and not by the cancer cells (Noe ¨l et al, 2001). The cancer cells can
recruit host cells, such as myofibroblasts, to become proteinase
factories. Indeed, except for MMP7, the overexpressed MMPs
found in the myofibroblastic desmoids, have previously been
described as MMPs mainly expressed by the stromal cells.
Increased expression of MMP1 has been observed in the stroma
around lung carcinomas (Curran and Murray, 1999), squamous
cell carcinomas of the head and neck and colorectal carcinomas.
Matrix metalloprotein 11 mRNA and protein were found
specifically in fibroblastic cells, immediately surrounding carcino-
ma cells (De Wever and Mareel, 2002). Here, we show that the
desmoid tumours themselves can induce the overexpression of
their MMPs, without being stimulated or influenced by epithelial
cancer cells. The data suggest that the desmoid cells synthesize
MMPs via an autocrine mechanism. This is in contrast to epithelial
cancers, where myofibroblasts are stimulated in a paracrine
manner by the tumour cells to produce MMPs. The fact
that myofibroblasts promote invasion of epithelial cancers
and can facilitate their own invasion through production of MMPs
suggests an important role for these cells in tumour invasion of a
variety of tumour types.
Figure 6 4,6-Diamidino-2-phenylindole-stained cells on the bottom
layer of the membrane. There was a significantly higher number of cells that
crossed the membrane in cultures treated with a carrier (A) than in cells
treated with an MMP inhibitor (B). There is some background staining
around the holes in the membrane. Scale bar¼100mm.
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sOur study shows a role for MMPs, facilitating the ability of
cells from desmoids to invade through the extracellular matrix.
In combination with data from other tumour types, it suggests
a common role for mesenchymal, myofibroblastic cells in
regulating cell invasion. Since desmoid tumours are locally
invasive, but not metastatic, strategies to slow their invasive
behaviour could lead to an effective therapy. Matrix metallo-
proteinase inhibitors have the potential to act as such
therapeutic agents, although further in vivo studies would be
required before adopting the use of such agents in clinical
practice.
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